Clinical Trial

A Study in Healthy People to Test How 2 Different Formulations of a Combination Treatment (Vicadrostat and Empagliflozin) Are Taken up in the Body and How Food Influences the Amount of the Medicines in the Blood

Completed Phase 1
View on ClinicalTrials.gov →
Summary
To investigate the relative bioavailability of two different vicadrostat/empagliflozin combinations. Additionally, the trial investigates the effect of food on the pharmacokinetics of the vicadrostat/empagliflozin.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-08-19; most recent amendment 2026-01-05.
Status change: Active, Not Recruiting → Completed 2025-10-30
Status change: Recruiting → Active, Not Recruiting 2025-10-15
Status change: Not Yet Recruiting → Recruiting 2025-09-15
Trial Details
NCT Number NCT07133399
Lead Sponsor Boehringer Ingelheim
Conditions Healthy
Enrollment 32 participants
Start Date 2025-09-08
Primary Completion 2025-10-22 (estimated)
Study Completion 2025-10-22 (estimated)
Updated on ClinicalTrials.gov 2026-01-06